Sutro Biopharma, Inc.
STRO
$40.05
-$0.86-2.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 141.43M | 167.59M | 205.13M | 248.97M | 316.90M |
| Total Receivables | 3.98M | 3.92M | 8.00M | 13.56M | 8.62M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.52M | 10.60M | 18.50M | 24.88M | 17.80M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 150.93M | 182.11M | 231.63M | 287.41M | 343.31M |
|
|
|||||
| Total Current Assets | 150.93M | 182.11M | 231.63M | 287.41M | 343.31M |
| Net Property, Plant & Equipment | 21.55M | 26.69M | 29.82M | 33.08M | 35.87M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.35M | 858.00K | 908.00K | 943.00K | 8.03M |
| Total Assets | 173.83M | 209.66M | 262.36M | 321.43M | 387.21M |
|
|
|||||
| Total Accounts Payable | 7.57M | 7.03M | 4.31M | 8.18M | 10.48M |
| Total Accrued Expenses | 46.31M | 32.14M | 49.92M | 33.95M | 40.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.78M | 7.96M | 8.06M | 7.77M | 7.48M |
| Total Finance Division Other Current Liabilities | 13.48M | 24.77M | 11.96M | 83.15M | 73.81M |
| Total Other Current Liabilities | 13.48M | 24.77M | 11.96M | 83.15M | 73.81M |
| Total Current Liabilities | 75.13M | 71.90M | 74.25M | 133.05M | 131.89M |
|
|
|||||
| Total Current Liabilities | 75.13M | 71.90M | 74.25M | 133.05M | 131.89M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.89M | 9.70M | 11.54M | 13.63M | 15.67M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 223.26M | 215.33M | 208.68M | 200.56M | 195.04M |
| Total Liabilities | 306.28M | 296.93M | 294.47M | 347.24M | 342.61M |
|
|
|||||
| Common Stock & APIC | 845.48M | 843.89M | 842.24M | 837.04M | 831.43M |
| Retained Earnings | -977.96M | -931.19M | -874.34M | -862.84M | -786.87M |
| Treasury Stock & Other | 19.00K | 33.00K | -13.00K | -9.00K | 39.00K |
| Total Common Equity | -132.45M | -87.27M | -32.11M | -25.81M | 44.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -132.45M | -87.27M | -32.11M | -25.81M | 44.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -132.45M | -87.27M | -32.11M | -25.81M | 44.60M |
|
|
|||||